Truveta Research on increased speech delays in children during the pandemic published in JAMA Pediatrics
December 05, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new research published in JAMA Pediatrics exploring the incidence of first-time speech delays in children under the age of...
Truveta welcomes Patrick Caubel, Pfizer Chief Safety Officer, to its Board of Directors
December 04, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Truveta, the company with a mission of saving lives with data, welcomes its first member from the life science industry to its Board of Directors....
Largest real-world study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss
November 27, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new comparative effectiveness research exploring weight loss among patients taking semaglutide (Ozempic) and tirzepatide...
Truveta announces availability of millions of echocardiogram reports to advance cardiovascular research
November 08, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced the availability of more than 56.6 million clinical observations from more than 2.7 million echocardiogram reports from...
Data on Early Clinical Benefit for INPEFA® (Sotagliflozin) Will Be Among Five Lexicon-Sponsored Presentations at the American Heart Association Scientific Sessions 2023
November 02, 2023 09:00 ET
|
Lexicon Pharmaceuticals, Inc.
Cost-effectiveness data and analyses of financial impact among patients hospitalized for heart failure and treated with INPEFA included as important data selected for presentation INPEFA®...
More than 50 organizations choose Truveta for the most complete, timely, and clean EHR data to study safety and effectiveness, improve patient care, and train medical AI
October 23, 2023 09:00 ET
|
Truveta
Bellevue, WASH., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Truveta announced today that it is partnering with more than 50 organizations in life sciences, healthcare, government, academic medical centers,...
Expert Panelists Advocate Use of Daxor’s Technology to Optimize Treatment at Heart Failure Society of America Annual Scientific Meeting
October 13, 2023 08:00 ET
|
Daxor Corporation
Leading Clinicians Highlight Significant Outcome Improvements with Daxor’s Blood Volume Analysis Innovative Technology Oak Ridge, TN, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq:...
OrthoPediatrics Joins Alliance for Pediatric Device Innovation
October 12, 2023 08:05 ET
|
OrthoPediatrics Corp.
WARSAW, Ind., Oct. 12, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively on advancing the field of pediatric...
Truveta advances security and privacy with Type 2 SOC 2 examination
October 11, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Truveta today announced it has completed a Type 2 System and Organization Controls (SOC) 2 examination, which underscores Truveta’s commitments to...
Alliance for Pediatric Device Innovation announces MedTech Color edition of “Make Your Medical Device Pitch For Kids!”™ supporting African American and Hispanic innovators
October 10, 2023 09:31 ET
|
Children's National Hospital
WASHINGTON, D.C., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Alliance for Pediatric Device Innovation (APDI), the federally funded consortium led by Children’s National Hospital, is joining with MedTech...